Biomerieux 69 Marcy (BMXMF) 109.8778 $BMXMF
Enteric Diseases in Germany 2014: Market Outlook and Emerging Opportunities
M2 - Wed May 07, 3:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mwhxpk/enteric_diseases) has announced the addition of the "Enteric Diseases in Germany 2014: Market Outlook and Emerging Opportunities" report to their offering. This new 322-page report presents detailed analysis of the German Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used for microbiology testing; - Profiles key suppliers and potential market entrants developing innovative technologies and products; and - Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as the author's proprietary data files was conducted. Key Topics Covered: I. Introduction II. Worldwide Market and Technology Overview A. Major Infectious Disease Tests B. Instrumentation Review of Leading Analyzers Marketed By Abbott, Beckman Coulter/Danaher, BioMerieux, OrthoClinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers C. Emerging Diagnostic Technologies III. Germany: Market Size, Growth and Major Suppliers' Sales and Market Shares Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies for Decentralized Testing Markets Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges Competitive Assessments: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - BioRad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio - GenProbe - Hologic - ID Biomedical Innogenetics/Solvay - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics - OrthoClinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac - Wako For more information visit http://www.researchandmarkets.com/research/mw...c_diseases
United States Molecular Diagnostics Market, Test Volume Forecast & Companies Report 2014-2018
M2 - Tue May 06, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8kwhmq/united_states) has announced the addition of the "United States (USA)-Molecular Diagnostics Market, Test Volume Forecast & Companies" report to their offering. United States Molecular Diagnostics Market & Future Forecast to 2018 Overview Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being added continuously. Molecular diagnostics is the promising area which can transform disease diagnosis, as diagnosis based on symptoms and use of surrogate markers is replaced by genomic and proteomic analysis. This fundamental shift offers the promise for early disease detection, potentially before symptoms have even occurred. United States molecular diagnostic market for 2018 is anticipated to more than double from its current value in 2013. In United States molecular diagnostic market, infectious disease controls the highest market share in 2013. But in terms of test volume food pathogen testing takes the lead pushing infectious disease at number two position. Molecular oncology tests have emerged as a significant rapidly growing market segment. In the current medical diagnostics market, molecular diagnostics for cancer testing offers one of the brightest areas for growth and innovation. United States constitutes the largest regional market for blood screening and blood products. Molecular diagnostics is also starting to emerge as an important tool for HLA Testing, Food Pathogen Detection Testing and other disease areas. In companies market share Hologic Inc., Myriad Genetics and Becton Dickinson together these 3 companies control more than 50% market share for 2013. However Becton Dickinson is expected to lose its market share gradually and Roche is expected to take its place by 2018. United States Molecular Diagnostics Market & Test Volume - Application Segment Analysis (2010 - 2018) 1. Oncology Testing 2. Infectious Diseases 3. Genetic Testing 4. Blood Screening 5. Food Pathogen Testing 6. Tissue Typing (HLA Testing) United States Molecular Diagnostics - Company Wise Sales Analysis (2010 - 2018) 1. Roche 2. Abbott 3. Myriad Genetics 4. BioMerieux 5. Qiagen 6. Hologic Inc. 7. Becton Dickinson 8. Siemens 9. Cepheid 10. Others Key Topics Covered: 1. Executive Summary 2. United States Molecular Diagnostics Market, Test Volume & Forecast (2010 - 2018) 3. United States Molecular Diagnostics Market & Volume Share (2010 - 2018) 4. United States Molecular Diagnostics Market & Forecast - Application Wise 5. United States Molecular Diagnostics Test Volume - Application Wise 6. United States Molecular Diagnostics Market - Company Wise 7. United States Molecular Diagnostics Market - Driving Factors 8. United States Molecular Diagnostics Market - Challenges For more information visit http://www.researchandmarkets.com/research/8k...ted_states
Global & USA Cancer Biomarker Market Analysis 2014-2018
M2 - Thu May 01, 8:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j6wrk6/global_and_usa) has announced the addition of the "Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends and Pipeline Analysis)" report to their offering. GLOBAL & USA CANCER BIOMARKER MARKET to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-development, Business Strategies, Industry Trends, and Pipeline Analysis) is a comprehensive report on the cancer biomarker industry and its impact on the health system. This report tackles the growing market interest in oncogenic biomarkers, personalized medicine, companion diagnostics and the associated market environment. Cancer biomarkers are molecular or genetic moieties (e.g., cells, proteins/peptides, genetic mutations, gene products, enzymes, or hormones) that not only are readily identifiable, but easily quantified in the lab setting. They function primarily to identify or correlate significantly with the severity or occurrence of a certain disease state. The rise in number of oncogenic biomarkers over the last number of years has massive potential in the healthcare industry and serves to propel both the personalized medicine and companion diagnostic markets. One of the most import aspects of biomarkers is their use to diagnose and assess the progress of disease states in patients. As quantitative markers, these agents also offer the ability to monitor response to certain drug treatments and so are important in the area of personalized medicine. Individualized, targeted or personalized medicine aims to increase the efficacy of therapeutics via genetic testing and companion diagnostics. Personalized therapeutics and associated companion diagnostics will be more specific and effective thereby giving pharma/biotech companies a significant advantage to recuperate R&D costs. Personalized medicine will reduce the frequency of adverse drug reactions and therefore have a dramatic impact on health economics. Developmental and diagnostic companies will benefit from lower discovery and commercialization costs and more specific market subtypes. This report describes the current technologies that are propelling the cancer biomarker and companion diagnostic market. It examines the current genetic diagnostic tests and companion diagnostic assays that are in use by the medical and pharmaceutical industry today. Current developments in personalized medicine and the pharmacogenomics revolution are discussed. The emerging trends that appear in the global market and the most developed market (US) are elucidated and analysed. This study reveals market figures of the overall biomarker market and the cancer biomarker space (2013-2018). Forecast projections and future growth rates are provided to give the reader a forthcoming perspective of this growing industry. In summary, the cancer biomarker and associated companion diagnostic market have huge opportunities for growth. This industry will revolutionize the healthcare system and will improve therapeutic effectiveness and reduce the severity of adverse effects. It has enormous potential for investment and the emergence of genetic-based in vitro diagnostics. Key Topics Covered: 1.0 Executive Summary 2.0 Global Burden of Cancer 3.0 Oncogenic Biomarkers - An Overview 4.0 Biomarker Validation 5.0 Current and Prospective Oncogenic Biomarkers 6.0 Cancer Biomarker Test Market Analysis 2013-2018 7.0 Oncology Biomarker Market Main Industry Players 8.0 Oncology Biomarker Market Products and Kits 9.0 Market Participant Financial and Business Strategy Analysis 10.0 Objective Business and Strategic Analysis of the Cancer Biomarker Market Companies Mentioned - 23andMe - Affymetrix - Ambry Genetics - Astex Pharmaceuticals - Atossa Genetics - BioMerieux - CuraGen - Celera Corporation (Quest Diagnostics) - Celldex Therapeutics - deCode Genetics (Amgen) - Foundation Medicine - Illumina - Genelex - Genomic Health - Myriad - Nodality - OriGene Technologies - Randox - Qiagen For more information visit http://www.researchandmarkets.com/research/j6...al_and_usa
Japan Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2014-2019
M2 - Tue Apr 22, 9:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3sfbk2/2014_japan) has announced the addition of the "2014 Japan Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Japanese molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in Japan; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood Group Genotyping PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing Microarrays BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du). Infectious Disease Screening Tests AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. Japan IV. Major Product Development Opportunities V. Alternative Market Penetration Strategies VI. Potential Market Entry Barriers and Risks VII. Competitive Assessments Companies Mentioned - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Bio-Rad - BioMerieux - Cepheid - Curtis Unyvero - Gen-Probe/Hologic - GenMark - Grifols - HTG - Immucor - Life Technologies - Nanosphere - Ortho-Clinical Diagnostics - Qiagen - Roche - Sarstedt - Siemens - Tecan For more information visit http://www.researchandmarkets.com/research/3sfbk2/2014_japan
Spain Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2014-2019
M2 - Tue Apr 22, 7:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lrkmls/2014_spain) has announced the addition of the "2014 Spain Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Spanish molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in Spain; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood Group Genotyping PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing Microarrays BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du). Infectious Disease Screening Tests AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. Spain IV. Major Product Development Opportunities V. Alternative Market Penetration Strategies VI. Potential Market Entry Barriers and Risks VII. Competitive Assessments Companies Mentioned - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/lrkmls/2014_spain
Germany Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2014-2019
M2 - Tue Apr 22, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cqq3lw/2014_germany) has announced the addition of the "2014 Germany Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the German molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in Germany; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood Group Genotyping PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing Microarrays BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du). Infectious Disease Screening Tests AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. Germany IV. Major Product Development Opportunities V. Alternative Market Penetration Strategies VI. Potential Market Entry Barriers and Risks VII. Competitive Assessments Companies Mentioned - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/cq...14_germany
Italy Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2014-2019
M2 - Tue Apr 22, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jbht28/2014_italy) has announced the addition of the "2014 Italy Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Italian molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in Italy; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood Group Genotyping PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing Microarrays BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du). Infectious Disease Screening Tests AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. Italy IV. Major Product Development Opportunities VI. Potential Market Entry Barriers and Risks VII. Competitive Assessments Companies Mentioned - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/jbht28/2014_italy
UK Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2014-2019
M2 - Tue Apr 22, 6:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ncptd6/2014_uk_molecular) has announced the addition of the "2014 UK Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the UK molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in UK; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. U.K. IV. Major Product Development Opportunities V. Alternative Market Penetration Strategies VI. Potential Market Entry Barriers and Risks VII. Competitive Assessments Companies Mentioned - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Bio-Rad - BioMerieux - Cepheid - Curtis Unyvero - Gen-Probe/Hologic - GenMark - Grifols - HTG - Immucor - Life Technologies - Nanosphere - Ortho-Clinical Diagnostics - Qiagen - Roche - Sarstedt - Siemens - Tecan For more information visit http://www.researchandmarkets.com/research/nc..._molecular
European Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2014-2019
M2 - Tue Apr 22, 6:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7vsqxt/2014_european) has announced the addition of the "2014 European Molecular Blood Typing, Grouping and Infectious Disease NAT Market: France, Germany, Italy, Spain, UK--Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated molecular and immunohematology analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood Group Genotyping PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR,Real Time PCR, Sanger DNA Sequencing, Pyrosequencing Microarrays BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du). Infectious Disease Screening Tests AIDS (HIV NAT, HIV-1/2), Cytomegalovirus,Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of blood typing, grouping and infectious disease screening tests by country and individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, M&A, product portfolios, marketing tactics, and new products in R&D. Market Segmentation Analysis - Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers, by country. - Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by country and market segment: - Blood Centers - Hospitals - Commercial/Private Laboratories Current and Emerging Products - Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays. - Review of automated and semi-automated molecular and immunohematology analyzers. Technology Review - Assessment of current and emerging technologies, and their potential applications for the blood banking market. - Comprehensive lists of companies developing or marketing new technologies and products, by test. Strategic Recommendations - New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Companies Mentioned - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/7v...4_european
France Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2014-2019
M2 - Tue Apr 22, 6:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xplzgf/2014_france) has announced the addition of the "2014 France Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the French molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in France; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood Group Genotyping PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing Microarrays BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du). Infectious Disease Screening Tests AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. France IV. Major Product Development Opportunities V. Alternative Market Penetration Strategies VI. Potential Market Entry Barriers and Risks VII. Competitive Assessments Companies Mentioned - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/xp...014_france About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
2014 US Molecular Blood Typing, Grouping and Infectious Disease NAT Market
M2 - Tue Apr 22, 6:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tz876x/2014_us_molecular) has announced the addition of the "2014 US Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the US molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in US; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood Group Genotyping PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing Microarrays BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du). Infectious Disease Screening Tests AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT Market Segmentation Analysis - Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers. - Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by market segment: - Blood Centers - Plasma Fractionation Facilities - Hospitals - Commercial/Private Laboratories - Military Blood Banks Current and Emerging Products - Analysis of current and emerging blood typing, grouping and infectious disease screening tests. - Review of automated and semi-automated analyzers. Technology Review - Assessment of current and emerging technologies, and their potential applications for the blood banking market. - Comprehensive lists of companies developing or marketing new technologies and products, by test. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Companies Mentioned - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - ImmucorOrchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/tz..._molecular
Concise Analysis of the International and Chinese Diagnostic Reagent Industry
M2 - Tue Mar 25, 6:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ch5ghd/global_and) has announced the addition of the "Concise Analysis of the International and Chinese Diagnostic Reagent Industry" report to their offering. The 'Concise Analysis of the International and Chinese Diagnostic Reagent Industry' is a professional and in-depth market research report on the global diagnostic reagent industry with a focus on the Chinese situation. The report first provides basic information on the diagnostic reagent industry, covering definitions, development overview, market share, classification and market demand trends. Diagnostics analysis is provided for both the international and Chinese domestic situations including sales revenue distribution, manufacturers and their market share, downstream industry demand and import/export analysis. Analysis for biochemical, immune, molecular and InVivo diagnostics sectors is carried out. A key feature of the report is its focus on 37 key industry players providing company information, diagnostic products, contact details and 2009-2017 Company Diagnostic Products Sales Revenue and Market Share. Upstream and downstream industry relationship and influence, as well as periodical regional and seasonal characteristics are discussed. Finally the feasibility of new investment projects report are investigates and overall research conclusions offered. With 295 tables and figures the report provides key statistics on the state of the diagnostic reagent industry and is a valuable source of guidance and direction for companies and individuals operating in the market. Key Topics Covered: Chapter One Diagnostic Reagent Overview Chapter Two InVitro Diagnostics Analysis Chapter Three Biochemical Diagnostics Analysis Chapter Four Immune Diagnostics Analysis Chapter Five Molecular Diagnostics Analysis Chapter Six InVivo Diagnostics Analysis Chapter Seven Global Diagnostic Agent Manufacturers Analysis Chapter Eight Up and Down Stream Industry Analysis and Influence Chapter Nine InVitro Diagnostics Industry SWOT Analysis and New Project Investment Feasibility Analysis Chapter Ten InVitro Diagnostics Industry Research Conclusion Companies Mentioned: - AMRESCO - Abbott - Abcam - Accurex - Anand Brothers - AusBio - BD - BIOMERIEUX - Beckman Coulter - Beijing Jiuqiang - Beijing Wantai - Bejing Kinghawk - Bio-Rad - Biokit - Biosino - DIRUI - Daan Gene - Euroimmun - FosunPharma - GE - InTec - Johnson & Johnson - KHB - Leadman - Life Technologies - Livzon - MBL - Nantong Union Bio - Prionics - Qiagen - R&D Systems - R-Biopharm - Roche - Rsbio - SIMENS - Snibe - Wondfo For more information visit http://www.researchandmarkets.com/research/ch5ghd/global_and
Global Food Safety Testing Market Outlook 2018: The US Accounts for the Maximum Share of the Global Food Safety Testing Market
M2 - Tue Mar 18, 9:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x5hfqg/global_food) has announced the addition of the "Global Food Safety Testing Market Outlook 2018" report to their offering. In the latest research report Global Food Safety Testing Market Outlook 2018, analysts have studied the global food safety testing market in terms of contaminants and key markets. This research is an outcome of extensive primary & secondary research and thorough analysis of industry trends. For the study, we have conducted telephonic interviews with industry experts, such as several food safety testing labs and food safety testing equipment manufacturers. The report covers detailed analysis of the global food safety testing market, which has been further segmented into contaminants, and other key markets. The food safety testing market of contaminants (pathogen, pesticides, toxins and GMO) for 2018 has been forecasted. The author has found that pathogens occupy a considerable share in global food safety testing market by contaminants, after pesticides. Further, the future share for testing of contaminants by various methods has also been provided. Some of the commonly used methods for food safety testing are PCR, chromatography, ELISA, etc. Among all the methods, PCR is the most preferred food safety testing method for pathogens and GMO worldwide. On a similar note, chromatography dominates food pesticide and toxin testing method worldwide. Further, the author has provided the market forecasts of the global food safety testing market along with forecast for countries such as US, China and Europe till 2018. Besides, the author has also observed various food safety regulations in key countries to provide a complete understanding of the global food safety testing market. The report has further incorporated various drivers like technological advancements transforming food safety testing market, etc., which would fuel the growth of global food safety testing market. The author has also included a detailed competitive landscape which includes the business overview, key financials and recent developments of the major players in the industry. Companies Mentioned: -3M -Agilent Technologies -BioMerieux SA -BioRad -DuPont -Eurofins -Idexx Laboratories -Neogen Corporation -Qiagen -Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/x5...lobal_food About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Food Safety Testing Market Analysis - 2013 Edition Features Players such as Agilent, Eurofins and Qiagen
M2 - Tue Mar 11, 11:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hmjm8h/global_food) has announced the addition of the "Global Food Safety Testing Market Analysis" report to their offering. According to Global Food Safety Testing Market Analysis, a growing number of participants in the global food market, an increased oversight and monitoring of the manufacturing and supply processes, and the introduction of new automation technologies, all will be instrumental for an enormous growth in the global food testing market. Globalization of food trade, rising consumer awareness about the safety of their food products, increased incidences of food-borne diseases and automation in food testing labs are going to be the major drivers for the food testing market. Among the various segments in food testing, pathogen testing forms a major chunk. In this report, alongside pathogen testing, the authors also cover other important segments such as GMO and pesticide testing. The authors have highlighted key geographical markets such as the United States that is adopting high-end technological food testing programs to minimize risks from contamination. Policy decisions such as Food Modernization Act are being taken up to shift focus towards prevention. On the other hand, Europe, one of the largest importers of food, has been restricting itself with traditional testing technologies. In comparison, developing nations, like India and China, are going through a transformation phase, backed by increased spending from the government. The report analyzes the food safety testing market in these areas in the context of the upcoming technologies and regulatory reforms. According to this study, regulatory amendments and technological developments are indicative that the industry will experience prodigious growth in the coming future. Companies Mentioned: - 3M - Agilent - BioMerieux SA - BioRad - DuPont Qualicon - Eurofins - Idexx Laboratories - Neogen Corp. - Qiagen - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/hm...lobal_food About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Concise Analysis of the International Enzyme-Linked Immunosorbent Assay (ELISA) Market
M2 - Fri Feb 28, 5:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/zjkz2c/enzymelinked) has announced the addition of the "Concise Analysis of the International Enzyme-Linked Immunosorbent Assay (ELISA) Market" report to their offering. This report analyzes the worldwide markets for Enzyme-Linked Immunosorbent Assay (ELISA) in US$ Thousand by the following Product Segments: ELISA Kits, and ELISA Development Sets and Antibody Pairs. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 110 companies including many key and niche players such as: - American Laboratory Products Company - BD Biosciences - BioMerieux SA - Bio-Rad Laboratories, Inc. - EMD Millipore Corp. - Life Technologies Corporation - Ortho-Clinical Diagnostics, Inc. - R&D Systems, Inc. - Thermo Fisher Scientific, Inc. - ZEUS Scientific, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Immunochemistry - An Introduction 3. Product Overview 4. Product Innovations/Introductions 5. Recent Industry Activity 6. Focus On Select Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 110 (including Divisions/Subsidiaries - 117) - The United States (76) - Canada (3) - Japan (1) - Europe (28) - France (1) - Germany (
- The United Kingdom ( - Spain (1) - Rest of Europe (10) - Asia-Pacific (Excluding Japan) (9) For more information visit http://www.researchandmarkets.com/research/zj...zymelinked
2014 Analysis of the US Endocrine Function Testing Market: Hospitals, Commercial Labs, Physician Offices
M2 - Mon Feb 10, 3:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/cgfkld/2014_analysis_of) has announced the addition of the "2014 Analysis of the US Endocrine Function Testing Market: Hospitals, Commercial Labs, Physician Offices" report to their offering. This new 271-page report provides a comprehensive analysis in the US endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab and TSH. During the next five years, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. 2013 Endocrine Function Testing Market in France: Hospitals and Commercial Labs is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts; compares features of leading analyzers; and profiles key competitors. Key Topics Covered: Introduction Worldwide Market and Technology Overview A. Major Endocrine Function Tests B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers C. Major In Vitro Diagnostic Technologies and Their Potential Applications D. Market Size, Growth and Major Supplier Shares Design Criteria for Decentralized Testing Products Alternative Market Penetration Strategies Potential Market Entry Barriers and Risks Competitive Assessments - Abbott Laboratories - AdnaGen - Agilent Technologies - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - DiaSorin - Eiken - Fujirebio/Innogenetics - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Quest Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/cg...nalysis_of
2014 Analysis of the World Blood Banking Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
M2 - Mon Feb 10, 3:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/fg4rzr/2014_analysis_of) has announced the addition of the "2014 Analysis of the World Blood Banking Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities" report to their offering. This new report contains 800 pages, 240 tables and provides forecasts for 40 blood typing, grouping and infectious disease screening tests by country and market segment, as well as sales and market shares of leading reagent and instrument suppliers. The report is available by region, country and section: Regions: Global, Europe Countries: France, Germany, Italy, Japan, Spain, UK, USA Sections: Assays, Competitors, Instrumentation, Technologies To purchase a DataPack that includes (test volumes, sales forecasts, supplier shares) please Contact our Customer Service Team. Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview A. Major Blood Typing, Grouping and Infectious B. Instrumentation Review: Operating Characteristics, C. Major in Vitro Diagnostic Technologies And Their Potential Applications D. Worldwide Market Overview France Germany Italy Japan Spain U.K. U.S.A. Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Bio-Rad - BioMerieux - Gen-Probe - Grifols - Immucor - Nanosphere - Ortho-Clinical Diagnostics - Roche - Sarstedt - Siemens - Tecan For more information visit http://www.researchandmarkets.com/research/fg...nalysis_of
2014 Analysis of the World Clinical Chemistry and Immunodiagnostic Markets: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
M2 - Mon Feb 10, 3:16AM CST
Research and Markets (http://www.researchandmarkets.com/research/nrl9dz/2014_analysis_of) has announced the addition of the "2014 Analysis of the World Clinical Chemistry and Immunodiagnostic Markets: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities" report to their offering. This new report contains 1,115 pages, 450 tables and provides forecasts for 100 tests by country and market segment, as well as sales and market shares for reagent and instrument suppliers. The report is available by region, country, section, market segment and test group: Regions:Global, Europe Countries: France, Germany, Italy, Japan, Spain, UK, USA. Sections: Assays, Competitors, Instrumentation,Technologies Market Segments: Home/Self Testing, Hospitals (France, Germany, Italy, Japan, Spain, UK, USA), Point-of-Care Test Groups: Diabetes/Glucose Testing, Drugs of Abuse, POC, Endocrine, Immunoproteins, Lipids, TDM, Tumor Markers/Specialty Chemistry To purchase a DataPack that includes (test volumes, sales forecasts, supplier shares) please Contact our Customer Service Team Key Topics Covered: Introduction Worldwide Market and Technology Overview A. Major Routine Chemistry Tests B. Therapeutic Drug Monitoring (TDM) C. Endocrine Function Tests D. Tumor Markers And Special Chemistry Tests E. Immunoprotein Tests F. Drugs of Abuse G. Instrumentation Review: Operating Characteristics H. Major In Vitro Diagnostic Technologies Germany Italy Japan Spain U.K. U.S.A. Companies Mentioned: - Abbott Laboratories - AdnaGen - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - Dako - DiaSorin - Eiken - Fujirebio - Instrumentation Laboratory - Kyowa Medex - Matritech - Ortho-Clinical Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/nr...nalysis_of About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Endocrine Function Diagnostics Market to See Considerable Changes in Next 10 Years, States VPG in Its Report Published at MarketPublishers.com
PRWeb - Wed Jan 15, 12:32PM CST
Currently, the diabetes testing represents the biggest market for the endocrine function diagnostics. The world prevalence of diabetes is anticipated to increase from nearly 382 million in 2013 to around 592 million in 2035, spurring considerably the global endocrine function diagnostics market. The main market growth stimulators include, among others, the high prevalence of some other diseases (hypothyroidism, polycystic ovary syndrome and hyperthyroidism, etc.), technological advancements in the endocrine function diagnostics, increasing healthcare IT penetration, steadily improving reimbursement and regulatory frameworks worldwide. North America is the dominant regional market for endocrine function diagnostics. BioMerieux, Beckman Coulter/Danaher, Instrumentation Laboratory, Roche, Kyowa Medex, Fujirebio, Abbott Laboratories, Thermo Fisher and Bio-Rad are among the entrenched players in the world endocrine function diagnostics market.
2014 Analysis of the UK Immunoprotein Diagnostic Testing Market: Hospitals and Commercial Labs
M2 - Mon Dec 16, 6:18AM CST
Research and Markets (http://www.researchandmarkets.com/research/2m9rjv/2014_analysis_of) has announced the addition of the "2014 Analysis of the UK Immunoprotein Diagnostic Testing Market: Hospitals and Commercial Labs" report to their offering. This new report provides analysis of the UK immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by market segment for the follow assays: - C3 - C4 - Free Light Chains - Haptoglobin - IgA - IgE Specific - IgE Total - IgG - IgM - Immunofixation - Prealbumin - Protein Electrophoresis During the next five years, the immunoprotein testing market will undergo significant transformation. The changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. Immunoprotein Diagnostic Testing in France: Hospitals and Commercial Labs is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts by market segment and individual test; compares features of leading analyzers; and profiles key competitors. Companies Mentioned: - Abbott Laboratories AdnaGen - Agilent Technologies - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - DiaSorin - Eiken - Fujirebio/Innogenetics - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Quest Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/2m...nalysis_of About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Enteric Diseases in Germany 2014: Market Outlook and Emerging Opportunities
M2 - Wed May 07, 3:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mwhxpk/enteric_diseases) has announced the addition of the "Enteric Diseases in Germany 2014: Market Outlook and Emerging Opportunities" report to their offering. This new 322-page report presents detailed analysis of the German Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used for microbiology testing; - Profiles key suppliers and potential market entrants developing innovative technologies and products; and - Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as the author's proprietary data files was conducted. Key Topics Covered: I. Introduction II. Worldwide Market and Technology Overview A. Major Infectious Disease Tests B. Instrumentation Review of Leading Analyzers Marketed By Abbott, Beckman Coulter/Danaher, BioMerieux, OrthoClinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers C. Emerging Diagnostic Technologies III. Germany: Market Size, Growth and Major Suppliers' Sales and Market Shares Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies for Decentralized Testing Markets Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges Competitive Assessments: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - BioRad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio - GenProbe - Hologic - ID Biomedical Innogenetics/Solvay - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics - OrthoClinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac - Wako For more information visit http://www.researchandmarkets.com/research/mw...c_diseases
United States Molecular Diagnostics Market, Test Volume Forecast & Companies Report 2014-2018
M2 - Tue May 06, 5:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8kwhmq/united_states) has announced the addition of the "United States (USA)-Molecular Diagnostics Market, Test Volume Forecast & Companies" report to their offering. United States Molecular Diagnostics Market & Future Forecast to 2018 Overview Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being added continuously. Molecular diagnostics is the promising area which can transform disease diagnosis, as diagnosis based on symptoms and use of surrogate markers is replaced by genomic and proteomic analysis. This fundamental shift offers the promise for early disease detection, potentially before symptoms have even occurred. United States molecular diagnostic market for 2018 is anticipated to more than double from its current value in 2013. In United States molecular diagnostic market, infectious disease controls the highest market share in 2013. But in terms of test volume food pathogen testing takes the lead pushing infectious disease at number two position. Molecular oncology tests have emerged as a significant rapidly growing market segment. In the current medical diagnostics market, molecular diagnostics for cancer testing offers one of the brightest areas for growth and innovation. United States constitutes the largest regional market for blood screening and blood products. Molecular diagnostics is also starting to emerge as an important tool for HLA Testing, Food Pathogen Detection Testing and other disease areas. In companies market share Hologic Inc., Myriad Genetics and Becton Dickinson together these 3 companies control more than 50% market share for 2013. However Becton Dickinson is expected to lose its market share gradually and Roche is expected to take its place by 2018. United States Molecular Diagnostics Market & Test Volume - Application Segment Analysis (2010 - 2018) 1. Oncology Testing 2. Infectious Diseases 3. Genetic Testing 4. Blood Screening 5. Food Pathogen Testing 6. Tissue Typing (HLA Testing) United States Molecular Diagnostics - Company Wise Sales Analysis (2010 - 2018) 1. Roche 2. Abbott 3. Myriad Genetics 4. BioMerieux 5. Qiagen 6. Hologic Inc. 7. Becton Dickinson 8. Siemens 9. Cepheid 10. Others Key Topics Covered: 1. Executive Summary 2. United States Molecular Diagnostics Market, Test Volume & Forecast (2010 - 2018) 3. United States Molecular Diagnostics Market & Volume Share (2010 - 2018) 4. United States Molecular Diagnostics Market & Forecast - Application Wise 5. United States Molecular Diagnostics Test Volume - Application Wise 6. United States Molecular Diagnostics Market - Company Wise 7. United States Molecular Diagnostics Market - Driving Factors 8. United States Molecular Diagnostics Market - Challenges For more information visit http://www.researchandmarkets.com/research/8k...ted_states
Global & USA Cancer Biomarker Market Analysis 2014-2018
M2 - Thu May 01, 8:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j6wrk6/global_and_usa) has announced the addition of the "Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends and Pipeline Analysis)" report to their offering. GLOBAL & USA CANCER BIOMARKER MARKET to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-development, Business Strategies, Industry Trends, and Pipeline Analysis) is a comprehensive report on the cancer biomarker industry and its impact on the health system. This report tackles the growing market interest in oncogenic biomarkers, personalized medicine, companion diagnostics and the associated market environment. Cancer biomarkers are molecular or genetic moieties (e.g., cells, proteins/peptides, genetic mutations, gene products, enzymes, or hormones) that not only are readily identifiable, but easily quantified in the lab setting. They function primarily to identify or correlate significantly with the severity or occurrence of a certain disease state. The rise in number of oncogenic biomarkers over the last number of years has massive potential in the healthcare industry and serves to propel both the personalized medicine and companion diagnostic markets. One of the most import aspects of biomarkers is their use to diagnose and assess the progress of disease states in patients. As quantitative markers, these agents also offer the ability to monitor response to certain drug treatments and so are important in the area of personalized medicine. Individualized, targeted or personalized medicine aims to increase the efficacy of therapeutics via genetic testing and companion diagnostics. Personalized therapeutics and associated companion diagnostics will be more specific and effective thereby giving pharma/biotech companies a significant advantage to recuperate R&D costs. Personalized medicine will reduce the frequency of adverse drug reactions and therefore have a dramatic impact on health economics. Developmental and diagnostic companies will benefit from lower discovery and commercialization costs and more specific market subtypes. This report describes the current technologies that are propelling the cancer biomarker and companion diagnostic market. It examines the current genetic diagnostic tests and companion diagnostic assays that are in use by the medical and pharmaceutical industry today. Current developments in personalized medicine and the pharmacogenomics revolution are discussed. The emerging trends that appear in the global market and the most developed market (US) are elucidated and analysed. This study reveals market figures of the overall biomarker market and the cancer biomarker space (2013-2018). Forecast projections and future growth rates are provided to give the reader a forthcoming perspective of this growing industry. In summary, the cancer biomarker and associated companion diagnostic market have huge opportunities for growth. This industry will revolutionize the healthcare system and will improve therapeutic effectiveness and reduce the severity of adverse effects. It has enormous potential for investment and the emergence of genetic-based in vitro diagnostics. Key Topics Covered: 1.0 Executive Summary 2.0 Global Burden of Cancer 3.0 Oncogenic Biomarkers - An Overview 4.0 Biomarker Validation 5.0 Current and Prospective Oncogenic Biomarkers 6.0 Cancer Biomarker Test Market Analysis 2013-2018 7.0 Oncology Biomarker Market Main Industry Players 8.0 Oncology Biomarker Market Products and Kits 9.0 Market Participant Financial and Business Strategy Analysis 10.0 Objective Business and Strategic Analysis of the Cancer Biomarker Market Companies Mentioned - 23andMe - Affymetrix - Ambry Genetics - Astex Pharmaceuticals - Atossa Genetics - BioMerieux - CuraGen - Celera Corporation (Quest Diagnostics) - Celldex Therapeutics - deCode Genetics (Amgen) - Foundation Medicine - Illumina - Genelex - Genomic Health - Myriad - Nodality - OriGene Technologies - Randox - Qiagen For more information visit http://www.researchandmarkets.com/research/j6...al_and_usa
Japan Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2014-2019
M2 - Tue Apr 22, 9:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3sfbk2/2014_japan) has announced the addition of the "2014 Japan Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Japanese molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in Japan; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood Group Genotyping PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing Microarrays BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du). Infectious Disease Screening Tests AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. Japan IV. Major Product Development Opportunities V. Alternative Market Penetration Strategies VI. Potential Market Entry Barriers and Risks VII. Competitive Assessments Companies Mentioned - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Bio-Rad - BioMerieux - Cepheid - Curtis Unyvero - Gen-Probe/Hologic - GenMark - Grifols - HTG - Immucor - Life Technologies - Nanosphere - Ortho-Clinical Diagnostics - Qiagen - Roche - Sarstedt - Siemens - Tecan For more information visit http://www.researchandmarkets.com/research/3sfbk2/2014_japan
Spain Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2014-2019
M2 - Tue Apr 22, 7:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lrkmls/2014_spain) has announced the addition of the "2014 Spain Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Spanish molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in Spain; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood Group Genotyping PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing Microarrays BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du). Infectious Disease Screening Tests AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. Spain IV. Major Product Development Opportunities V. Alternative Market Penetration Strategies VI. Potential Market Entry Barriers and Risks VII. Competitive Assessments Companies Mentioned - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/lrkmls/2014_spain
Germany Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2014-2019
M2 - Tue Apr 22, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cqq3lw/2014_germany) has announced the addition of the "2014 Germany Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the German molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in Germany; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood Group Genotyping PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing Microarrays BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du). Infectious Disease Screening Tests AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. Germany IV. Major Product Development Opportunities V. Alternative Market Penetration Strategies VI. Potential Market Entry Barriers and Risks VII. Competitive Assessments Companies Mentioned - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/cq...14_germany
Italy Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2014-2019
M2 - Tue Apr 22, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jbht28/2014_italy) has announced the addition of the "2014 Italy Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Italian molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in Italy; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood Group Genotyping PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing Microarrays BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du). Infectious Disease Screening Tests AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. Italy IV. Major Product Development Opportunities VI. Potential Market Entry Barriers and Risks VII. Competitive Assessments Companies Mentioned - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/jbht28/2014_italy
UK Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2014-2019
M2 - Tue Apr 22, 6:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ncptd6/2014_uk_molecular) has announced the addition of the "2014 UK Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the UK molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in UK; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. U.K. IV. Major Product Development Opportunities V. Alternative Market Penetration Strategies VI. Potential Market Entry Barriers and Risks VII. Competitive Assessments Companies Mentioned - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Bio-Rad - BioMerieux - Cepheid - Curtis Unyvero - Gen-Probe/Hologic - GenMark - Grifols - HTG - Immucor - Life Technologies - Nanosphere - Ortho-Clinical Diagnostics - Qiagen - Roche - Sarstedt - Siemens - Tecan For more information visit http://www.researchandmarkets.com/research/nc..._molecular
European Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2014-2019
M2 - Tue Apr 22, 6:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7vsqxt/2014_european) has announced the addition of the "2014 European Molecular Blood Typing, Grouping and Infectious Disease NAT Market: France, Germany, Italy, Spain, UK--Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated molecular and immunohematology analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood Group Genotyping PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR,Real Time PCR, Sanger DNA Sequencing, Pyrosequencing Microarrays BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du). Infectious Disease Screening Tests AIDS (HIV NAT, HIV-1/2), Cytomegalovirus,Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT. Sales and Market Share Analysis Sales and market share estimates for leading suppliers of blood typing, grouping and infectious disease screening tests by country and individual product. Competitive Assessments Strategic assessments of major suppliers and emerging market entrants, including their sales, M&A, product portfolios, marketing tactics, and new products in R&D. Market Segmentation Analysis - Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers, by country. - Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by country and market segment: - Blood Centers - Hospitals - Commercial/Private Laboratories Current and Emerging Products - Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays. - Review of automated and semi-automated molecular and immunohematology analyzers. Technology Review - Assessment of current and emerging technologies, and their potential applications for the blood banking market. - Comprehensive lists of companies developing or marketing new technologies and products, by test. Strategic Recommendations - New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Companies Mentioned - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/7v...4_european
France Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2014-2019
M2 - Tue Apr 22, 6:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xplzgf/2014_france) has announced the addition of the "2014 France Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the French molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in France; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood Group Genotyping PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing Microarrays BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du). Infectious Disease Screening Tests AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview III. France IV. Major Product Development Opportunities V. Alternative Market Penetration Strategies VI. Potential Market Entry Barriers and Risks VII. Competitive Assessments Companies Mentioned - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/xp...014_france About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
2014 US Molecular Blood Typing, Grouping and Infectious Disease NAT Market
M2 - Tue Apr 22, 6:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tz876x/2014_us_molecular) has announced the addition of the "2014 US Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the US molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report explores future marketing and technological trends in US; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years. Blood Group Genotyping PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing Microarrays BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du). Infectious Disease Screening Tests AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT Market Segmentation Analysis - Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers. - Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by market segment: - Blood Centers - Plasma Fractionation Facilities - Hospitals - Commercial/Private Laboratories - Military Blood Banks Current and Emerging Products - Analysis of current and emerging blood typing, grouping and infectious disease screening tests. - Review of automated and semi-automated analyzers. Technology Review - Assessment of current and emerging technologies, and their potential applications for the blood banking market. - Comprehensive lists of companies developing or marketing new technologies and products, by test. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Companies Mentioned - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - ImmucorOrchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/tz..._molecular
Concise Analysis of the International and Chinese Diagnostic Reagent Industry
M2 - Tue Mar 25, 6:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ch5ghd/global_and) has announced the addition of the "Concise Analysis of the International and Chinese Diagnostic Reagent Industry" report to their offering. The 'Concise Analysis of the International and Chinese Diagnostic Reagent Industry' is a professional and in-depth market research report on the global diagnostic reagent industry with a focus on the Chinese situation. The report first provides basic information on the diagnostic reagent industry, covering definitions, development overview, market share, classification and market demand trends. Diagnostics analysis is provided for both the international and Chinese domestic situations including sales revenue distribution, manufacturers and their market share, downstream industry demand and import/export analysis. Analysis for biochemical, immune, molecular and InVivo diagnostics sectors is carried out. A key feature of the report is its focus on 37 key industry players providing company information, diagnostic products, contact details and 2009-2017 Company Diagnostic Products Sales Revenue and Market Share. Upstream and downstream industry relationship and influence, as well as periodical regional and seasonal characteristics are discussed. Finally the feasibility of new investment projects report are investigates and overall research conclusions offered. With 295 tables and figures the report provides key statistics on the state of the diagnostic reagent industry and is a valuable source of guidance and direction for companies and individuals operating in the market. Key Topics Covered: Chapter One Diagnostic Reagent Overview Chapter Two InVitro Diagnostics Analysis Chapter Three Biochemical Diagnostics Analysis Chapter Four Immune Diagnostics Analysis Chapter Five Molecular Diagnostics Analysis Chapter Six InVivo Diagnostics Analysis Chapter Seven Global Diagnostic Agent Manufacturers Analysis Chapter Eight Up and Down Stream Industry Analysis and Influence Chapter Nine InVitro Diagnostics Industry SWOT Analysis and New Project Investment Feasibility Analysis Chapter Ten InVitro Diagnostics Industry Research Conclusion Companies Mentioned: - AMRESCO - Abbott - Abcam - Accurex - Anand Brothers - AusBio - BD - BIOMERIEUX - Beckman Coulter - Beijing Jiuqiang - Beijing Wantai - Bejing Kinghawk - Bio-Rad - Biokit - Biosino - DIRUI - Daan Gene - Euroimmun - FosunPharma - GE - InTec - Johnson & Johnson - KHB - Leadman - Life Technologies - Livzon - MBL - Nantong Union Bio - Prionics - Qiagen - R&D Systems - R-Biopharm - Roche - Rsbio - SIMENS - Snibe - Wondfo For more information visit http://www.researchandmarkets.com/research/ch5ghd/global_and
Global Food Safety Testing Market Outlook 2018: The US Accounts for the Maximum Share of the Global Food Safety Testing Market
M2 - Tue Mar 18, 9:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x5hfqg/global_food) has announced the addition of the "Global Food Safety Testing Market Outlook 2018" report to their offering. In the latest research report Global Food Safety Testing Market Outlook 2018, analysts have studied the global food safety testing market in terms of contaminants and key markets. This research is an outcome of extensive primary & secondary research and thorough analysis of industry trends. For the study, we have conducted telephonic interviews with industry experts, such as several food safety testing labs and food safety testing equipment manufacturers. The report covers detailed analysis of the global food safety testing market, which has been further segmented into contaminants, and other key markets. The food safety testing market of contaminants (pathogen, pesticides, toxins and GMO) for 2018 has been forecasted. The author has found that pathogens occupy a considerable share in global food safety testing market by contaminants, after pesticides. Further, the future share for testing of contaminants by various methods has also been provided. Some of the commonly used methods for food safety testing are PCR, chromatography, ELISA, etc. Among all the methods, PCR is the most preferred food safety testing method for pathogens and GMO worldwide. On a similar note, chromatography dominates food pesticide and toxin testing method worldwide. Further, the author has provided the market forecasts of the global food safety testing market along with forecast for countries such as US, China and Europe till 2018. Besides, the author has also observed various food safety regulations in key countries to provide a complete understanding of the global food safety testing market. The report has further incorporated various drivers like technological advancements transforming food safety testing market, etc., which would fuel the growth of global food safety testing market. The author has also included a detailed competitive landscape which includes the business overview, key financials and recent developments of the major players in the industry. Companies Mentioned: -3M -Agilent Technologies -BioMerieux SA -BioRad -DuPont -Eurofins -Idexx Laboratories -Neogen Corporation -Qiagen -Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/x5...lobal_food About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Food Safety Testing Market Analysis - 2013 Edition Features Players such as Agilent, Eurofins and Qiagen
M2 - Tue Mar 11, 11:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hmjm8h/global_food) has announced the addition of the "Global Food Safety Testing Market Analysis" report to their offering. According to Global Food Safety Testing Market Analysis, a growing number of participants in the global food market, an increased oversight and monitoring of the manufacturing and supply processes, and the introduction of new automation technologies, all will be instrumental for an enormous growth in the global food testing market. Globalization of food trade, rising consumer awareness about the safety of their food products, increased incidences of food-borne diseases and automation in food testing labs are going to be the major drivers for the food testing market. Among the various segments in food testing, pathogen testing forms a major chunk. In this report, alongside pathogen testing, the authors also cover other important segments such as GMO and pesticide testing. The authors have highlighted key geographical markets such as the United States that is adopting high-end technological food testing programs to minimize risks from contamination. Policy decisions such as Food Modernization Act are being taken up to shift focus towards prevention. On the other hand, Europe, one of the largest importers of food, has been restricting itself with traditional testing technologies. In comparison, developing nations, like India and China, are going through a transformation phase, backed by increased spending from the government. The report analyzes the food safety testing market in these areas in the context of the upcoming technologies and regulatory reforms. According to this study, regulatory amendments and technological developments are indicative that the industry will experience prodigious growth in the coming future. Companies Mentioned: - 3M - Agilent - BioMerieux SA - BioRad - DuPont Qualicon - Eurofins - Idexx Laboratories - Neogen Corp. - Qiagen - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/hm...lobal_food About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Concise Analysis of the International Enzyme-Linked Immunosorbent Assay (ELISA) Market
M2 - Fri Feb 28, 5:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/zjkz2c/enzymelinked) has announced the addition of the "Concise Analysis of the International Enzyme-Linked Immunosorbent Assay (ELISA) Market" report to their offering. This report analyzes the worldwide markets for Enzyme-Linked Immunosorbent Assay (ELISA) in US$ Thousand by the following Product Segments: ELISA Kits, and ELISA Development Sets and Antibody Pairs. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 110 companies including many key and niche players such as: - American Laboratory Products Company - BD Biosciences - BioMerieux SA - Bio-Rad Laboratories, Inc. - EMD Millipore Corp. - Life Technologies Corporation - Ortho-Clinical Diagnostics, Inc. - R&D Systems, Inc. - Thermo Fisher Scientific, Inc. - ZEUS Scientific, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Immunochemistry - An Introduction 3. Product Overview 4. Product Innovations/Introductions 5. Recent Industry Activity 6. Focus On Select Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 110 (including Divisions/Subsidiaries - 117) - The United States (76) - Canada (3) - Japan (1) - Europe (28) - France (1) - Germany (
- The United Kingdom ( - Spain (1) - Rest of Europe (10) - Asia-Pacific (Excluding Japan) (9) For more information visit http://www.researchandmarkets.com/research/zj...zymelinked 2014 Analysis of the US Endocrine Function Testing Market: Hospitals, Commercial Labs, Physician Offices
M2 - Mon Feb 10, 3:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/cgfkld/2014_analysis_of) has announced the addition of the "2014 Analysis of the US Endocrine Function Testing Market: Hospitals, Commercial Labs, Physician Offices" report to their offering. This new 271-page report provides a comprehensive analysis in the US endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab and TSH. During the next five years, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. 2013 Endocrine Function Testing Market in France: Hospitals and Commercial Labs is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts; compares features of leading analyzers; and profiles key competitors. Key Topics Covered: Introduction Worldwide Market and Technology Overview A. Major Endocrine Function Tests B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers C. Major In Vitro Diagnostic Technologies and Their Potential Applications D. Market Size, Growth and Major Supplier Shares Design Criteria for Decentralized Testing Products Alternative Market Penetration Strategies Potential Market Entry Barriers and Risks Competitive Assessments - Abbott Laboratories - AdnaGen - Agilent Technologies - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - DiaSorin - Eiken - Fujirebio/Innogenetics - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Quest Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/cg...nalysis_of
2014 Analysis of the World Blood Banking Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
M2 - Mon Feb 10, 3:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/fg4rzr/2014_analysis_of) has announced the addition of the "2014 Analysis of the World Blood Banking Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities" report to their offering. This new report contains 800 pages, 240 tables and provides forecasts for 40 blood typing, grouping and infectious disease screening tests by country and market segment, as well as sales and market shares of leading reagent and instrument suppliers. The report is available by region, country and section: Regions: Global, Europe Countries: France, Germany, Italy, Japan, Spain, UK, USA Sections: Assays, Competitors, Instrumentation, Technologies To purchase a DataPack that includes (test volumes, sales forecasts, supplier shares) please Contact our Customer Service Team. Key Topics Covered: I. Introduction II. Worldwide Technology and Market Overview A. Major Blood Typing, Grouping and Infectious B. Instrumentation Review: Operating Characteristics, C. Major in Vitro Diagnostic Technologies And Their Potential Applications D. Worldwide Market Overview France Germany Italy Japan Spain U.K. U.S.A. Companies Mentioned: - Abbott - Beckman Coulter/Danaher - Bio-Rad - BioMerieux - Gen-Probe - Grifols - Immucor - Nanosphere - Ortho-Clinical Diagnostics - Roche - Sarstedt - Siemens - Tecan For more information visit http://www.researchandmarkets.com/research/fg...nalysis_of
2014 Analysis of the World Clinical Chemistry and Immunodiagnostic Markets: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
M2 - Mon Feb 10, 3:16AM CST
Research and Markets (http://www.researchandmarkets.com/research/nrl9dz/2014_analysis_of) has announced the addition of the "2014 Analysis of the World Clinical Chemistry and Immunodiagnostic Markets: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities" report to their offering. This new report contains 1,115 pages, 450 tables and provides forecasts for 100 tests by country and market segment, as well as sales and market shares for reagent and instrument suppliers. The report is available by region, country, section, market segment and test group: Regions:Global, Europe Countries: France, Germany, Italy, Japan, Spain, UK, USA. Sections: Assays, Competitors, Instrumentation,Technologies Market Segments: Home/Self Testing, Hospitals (France, Germany, Italy, Japan, Spain, UK, USA), Point-of-Care Test Groups: Diabetes/Glucose Testing, Drugs of Abuse, POC, Endocrine, Immunoproteins, Lipids, TDM, Tumor Markers/Specialty Chemistry To purchase a DataPack that includes (test volumes, sales forecasts, supplier shares) please Contact our Customer Service Team Key Topics Covered: Introduction Worldwide Market and Technology Overview A. Major Routine Chemistry Tests B. Therapeutic Drug Monitoring (TDM) C. Endocrine Function Tests D. Tumor Markers And Special Chemistry Tests E. Immunoprotein Tests F. Drugs of Abuse G. Instrumentation Review: Operating Characteristics H. Major In Vitro Diagnostic Technologies Germany Italy Japan Spain U.K. U.S.A. Companies Mentioned: - Abbott Laboratories - AdnaGen - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - Dako - DiaSorin - Eiken - Fujirebio - Instrumentation Laboratory - Kyowa Medex - Matritech - Ortho-Clinical Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/nr...nalysis_of About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Endocrine Function Diagnostics Market to See Considerable Changes in Next 10 Years, States VPG in Its Report Published at MarketPublishers.com
PRWeb - Wed Jan 15, 12:32PM CST
Currently, the diabetes testing represents the biggest market for the endocrine function diagnostics. The world prevalence of diabetes is anticipated to increase from nearly 382 million in 2013 to around 592 million in 2035, spurring considerably the global endocrine function diagnostics market. The main market growth stimulators include, among others, the high prevalence of some other diseases (hypothyroidism, polycystic ovary syndrome and hyperthyroidism, etc.), technological advancements in the endocrine function diagnostics, increasing healthcare IT penetration, steadily improving reimbursement and regulatory frameworks worldwide. North America is the dominant regional market for endocrine function diagnostics. BioMerieux, Beckman Coulter/Danaher, Instrumentation Laboratory, Roche, Kyowa Medex, Fujirebio, Abbott Laboratories, Thermo Fisher and Bio-Rad are among the entrenched players in the world endocrine function diagnostics market.
2014 Analysis of the UK Immunoprotein Diagnostic Testing Market: Hospitals and Commercial Labs
M2 - Mon Dec 16, 6:18AM CST
Research and Markets (http://www.researchandmarkets.com/research/2m9rjv/2014_analysis_of) has announced the addition of the "2014 Analysis of the UK Immunoprotein Diagnostic Testing Market: Hospitals and Commercial Labs" report to their offering. This new report provides analysis of the UK immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by market segment for the follow assays: - C3 - C4 - Free Light Chains - Haptoglobin - IgA - IgE Specific - IgE Total - IgG - IgM - Immunofixation - Prealbumin - Protein Electrophoresis During the next five years, the immunoprotein testing market will undergo significant transformation. The changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. Immunoprotein Diagnostic Testing in France: Hospitals and Commercial Labs is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts by market segment and individual test; compares features of leading analyzers; and profiles key competitors. Companies Mentioned: - Abbott Laboratories AdnaGen - Agilent Technologies - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - DiaSorin - Eiken - Fujirebio/Innogenetics - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Quest Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/2m...nalysis_of About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
